| CD8+ cytotoxic T lymphocytes in cancer immunotherapy: A review B Farhood, M Najafi, K Mortezaee Journal of cellular physiology 234 (6), 8509-8521, 2019 | 1227 | 2019 |
| Cyclooxygenase‐2 in cancer: a review N Hashemi Goradel, M Najafi, E Salehi, B Farhood, K Mortezaee Journal of cellular physiology 234 (5), 5683-5699, 2019 | 602 | 2019 |
| Extracellular matrix (ECM) stiffness and degradation as cancer drivers M Najafi, B Farhood, K Mortezaee Journal of cellular biochemistry 120 (3), 2782-2790, 2019 | 487 | 2019 |
| Cancer stem cells (CSCs) in cancer progression and therapy M Najafi, B Farhood, K Mortezaee Journal of cellular physiology 234 (6), 8381-8395, 2019 | 431 | 2019 |
| Macrophage polarity in cancer: a review M Najafi, N Hashemi Goradel, B Farhood, E Salehi, MS Nashtaei, ... Journal of cellular biochemistry 120 (3), 2756-2765, 2019 | 430 | 2019 |
| Mechanisms of apoptosis modulation by curcumin: Implications for cancer therapy K Mortezaee, E Salehi, H Mirtavoos‐mahyari, E Motevaseli, M Najafi, ... Journal of cellular physiology 234 (8), 12537-12550, 2019 | 271 | 2019 |
| Incidence and mortality of various cancers in Iran and compare to other countries: a review article B Farhood, G Geraily, A Alizadeh Iranian journal of public health 47 (3), 309, 2018 | 261 | 2018 |
| Curcumin as an anti‐inflammatory agent: Implications to radiotherapy and chemotherapy B Farhood, K Mortezaee, NH Goradel, N Khanlarkhani, E Salehi, ... Journal of cellular physiology 234 (5), 5728-5740, 2019 | 226 | 2019 |
| Tumor microenvironment: Interactions and therapy M Najafi, NH Goradel, B Farhood, E Salehi, S Solhjoo, H Toolee, ... Journal of cellular physiology 234 (5), 5700-5721, 2019 | 178 | 2019 |
| Contribution of regulatory T cells to cancer: A review M Najafi, B Farhood, K Mortezaee Journal of cellular physiology 234 (6), 7983-7993, 2019 | 172 | 2019 |
| Folic acid functionalized nanoparticles as pharmaceutical carriers in drug delivery systems A Narmani, M Rezvani, B Farhood, P Darkhor, J Mohammadnejad, ... Drug development research 80 (4), 404-424, 2019 | 157 | 2019 |
| Radiation-induced inflammation and autoimmune diseases R Yahyapour, P Amini, S Rezapour, M Cheki, A Rezaeyan, B Farhood, ... Military Medical Research 5, 1-8, 2018 | 143 | 2018 |
| Melatonin as an adjuvant in radiotherapy for radioprotection and radiosensitization B Farhood, NH Goradel, K Mortezaee, N Khanlarkhani, E Salehi, ... Clinical and Translational Oncology 21, 268-279, 2019 | 135 | 2019 |
| Reduction–oxidation (redox) system in radiation-induced normal tissue injury: molecular mechanisms and implications in radiation therapeutics R Yahyapour, E Motevaseli, A Rezaeyan, H Abdollahi, B Farhood, ... Clinical and Translational Oncology 20, 975-988, 2018 | 133 | 2018 |
| Fusobacterium nucleatum and colorectal cancer: A mechanistic overview N Hashemi Goradel, S Heidarzadeh, S Jahangiri, B Farhood, ... Journal of Cellular Physiology 234 (3), 2337-2344, 2019 | 131 | 2019 |
| Transforming growth factor‐β signaling: tumorigenesis and targeting for cancer therapy A Ahmadi, M Najafi, B Farhood, K Mortezaee Journal of cellular physiology 234 (8), 12173-12187, 2019 | 128 | 2019 |
| Modulation of apoptosis by melatonin for improving cancer treatment efficiency: An updated review K Mortezaee, M Najafi, B Farhood, A Ahmadi, Y Potes, D Shabeeb, ... Life sciences 228, 228-241, 2019 | 121 | 2019 |
| Synergic effects of nanoparticles-mediated hyperthermia in radiotherapy/chemotherapy of cancer K Mortezaee, A Narmani, M Salehi, H Bagheri, B Farhood, ... Life sciences 269, 119020, 2021 | 108 | 2021 |
| TGF-β in radiotherapy: Mechanisms of tumor resistance and normal tissues injury B Farhood, M Hoseini-Ghahfarokhi, E Motevaseli, H Mirtavoos-Mahyari, ... Pharmacological research 155, 104745, 2020 | 108 | 2020 |
| Hypoxia in solid tumors: a key promoter of cancer stem cell (CSC) resistance M Najafi, B Farhood, K Mortezaee, E Kharazinejad, J Majidpoor, R Ahadi Journal of cancer research and clinical oncology 146, 19-31, 2020 | 105 | 2020 |
